Abound Wealth Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.5K Sell
726
-54
-7% -$3.55K 0.01% 247
2026
Q1
$55.5K Sell
780
-8
-1% -$631 0.01% 231
2025
Q4
$64.6K Buy
788
+705
+849% +$54.9K 0.02% 193
2025
Q3
$6.21K Sell
83
-37
-31% -$2.76K ﹤0.01% 598
2025
Q2
$8.87K Hold
120
﹤0.01% 466
2025
Q1
$9.66K Buy
120
+12
+11% +$1.03K ﹤0.01% 410
2024
Q4
$8.42K Sell
108
-42
-28% -$3.57K ﹤0.01% 421
2024
Q3
$14.1K Sell
150
-25
-14% -$2.1K ﹤0.01% 358
2024
Q2
$13.6K Sell
175
-141
-45% -$11.5K 0.01% 320
2024
Q1
$28.7K Sell
316
-42
-12% -$3.5K 0.01% 197
2023
Q4
$27.7K Sell
358
-76
-18% -$5.32K 0.01% 210
2023
Q3
$29.5K Sell
434
-76
-15% -$5.53K 0.01% 182
2023
Q2
$41.4K Sell
510
-26
-5% -$2.08K 0.02% 151
2023
Q1
$44K Buy
+536
New +$38.3K 0.02% 136

Other funds holding GEHC

Abound Wealth Management's GEHC Position: Q2 2026 in Review

Abound Wealth Management reduced its GE HealthCare (GEHC) stake by 6.9% in Q2 2026, selling an estimated $3.55K and leaving 726 shares worth $46.5K. The position accounts for 0.01% of the portfolio, ranked #247.

Abound Wealth Management first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $64.6K in Q4 2025. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Abound Wealth Management held 726 shares of GE HealthCare worth $46.5K as of Q2 2026.
  • Abound Wealth Management sold 54 GE HealthCare shares in Q2 2026, an estimated $3.55K.
  • GE HealthCare made up 0.01% of Abound Wealth Management's portfolio in Q2 2026, its #247 holding.
  • Abound Wealth Management first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Abound Wealth Management's GE HealthCare position peaked at $64.6K in Q4 2025.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.